Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
EMA Agile governance model
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
List of centrally authorised products with safety-related changes to the product information
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 10, Status: Authorised
Business process description for scientific meeting management
Business process description for expert management
ICH Q1 guideline on stability testing of drug substances and drug products